Trial Search Results

BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

The purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility of efficacy) of the ability of people with tetraplegia to control a computer cursor and other assistive devices with their thoughts.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Leigh R. Hochberg, MD, PhD.

Collaborator: National Institute of Neurological Disorders and Stroke (NINDS)

Stanford Investigator(s):


  • Device: Placement of the BrainGate2 sensor(s) into the motor-related cortex




Inclusion Criteria:

   - Clinical diagnosis of spinal cord injury, brainstem stroke, muscular dystrophy,
   amyotrophic lateral sclerosis or other motor neuron disorders

   - Complete or incomplete tetraplegia (quadriplegia)

   - Must live within a three-hour drive of the Study site

   - (There are additional inclusion criteria)

Exclusion Criteria:

   - Visual impairment such that extended viewing of a computer monitor would be difficult
   even with ordinary corrective lenses

   - Chronic oral or intravenous steroids or immunosuppressive therapy

   - Other serious disease or disorder that could seriously affect ability to participate
   in the study

   - (There are additional exclusion criteria)

Ages Eligible for Study

18 Years - 75 Years

Genders Eligible for Study


Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Maria Coburn
650 736 9551